 Analgesics
|
Nonsteroidal Anti-inflammatory Drugs
|
 Celecoxib
|
Diclofenac [DG:DG00441]
|
Diflunisal
|
Etodolac
|
Fenoprofen [DG:DG00754]
|
Flurbiprofen [DG:DG00755]
|
 D00330 Flurbiprofen (JP17/USP/INN)
D01475 Flurbiprofen axetil (JAN)
D02290 Flurbiprofen sodium (USP)
D10254 Esflurbiprofen (JAN)
|
Ibuprofen [DG:DG00245]
|
Indomethacin [DG:DG00241]
|
Ketoprofen [DG:DG00753]
|
Ketorolac [DG:DG00751]
|
Meclofenamate [DG:DG00758]
|
Mefenamic acid
|
Meloxicam
|
Nabumetone
|
Naproxen [DG:DG00455]
|
Oxaprozin
|
Piroxicam [DG:DG00752]
|
Sulindac
|
Tolmetin [DG:DG00747]
|
Opioid Analgesics, Long-acting
|
Opioid Analgesics, Short-acting
|
|
Anesthetics
|
|
Anti-Addiction/Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
Glucocorticoids
|
Nonsteroidal Anti-inflammatory Drugs
|
Celecoxib
|
Diclofenac [DG:DG00441]
|
Diflunisal
|
Etodolac
|
Fenoprofen [DG:DG00754]
|
Flurbiprofen [DG:DG00755]
|
D00330 Flurbiprofen (JP17/USP/INN)
D01475 Flurbiprofen axetil (JAN)
D02290 Flurbiprofen sodium (USP)
D10254 Esflurbiprofen (JAN)
|
Ibuprofen [DG:DG00245]
|
Indomethacin [DG:DG00241]
|
Ketoprofen [DG:DG00753]
|
Ketorolac [DG:DG00751]
|
Meclofenamate [DG:DG00758]
|
Mefenamic acid
|
Meloxicam
|
Nabumetone
|
Naproxen [DG:DG00455]
|
Oxaprozin
|
Piroxicam [DG:DG00752]
|
Sulindac
|
Tolmetin [DG:DG00747]
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products/Modifiers/Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Electrolytes/Minerals/Metals/Vitamins
|
|
Gastrointestinal Agents
|
|
Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
|
|
Genitourinary Agents
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
|
Hormonal Agents, Suppressant (Adrenal)
|
|
Hormonal Agents, Suppressant (Pituitary)
|
|
Hormonal Agents, Suppressant (Thyroid)
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
Ophthalmic Anti-allergy Agents
|
Ophthalmic Antiglaucoma Agents
|
Ophthalmic Anti-inflammatories
|
Dexamethasone [DG:DG00011]
|
Difluprednate
|
Fluocinolone
|
Loteprednol [DG:DG01127]
|
Prednisolone [DG:DG00093]
|
Rimexolone
|
Bromfenac [DG:DG01128]
|
Diclofenac [DG:DG00441]
|
Flurbiprofen [DG:DG00755]
|
D00330 Flurbiprofen (JP17/USP/INN)
D01475 Flurbiprofen axetil (JAN)
D02290 Flurbiprofen sodium (USP)
D10254 Esflurbiprofen (JAN)
|
Ketorolac [DG:DG00751]
|
Nepafenac
|
Ophthalmic Prostaglandin and Prostamide Analogs
|
Ophthalmic Agents, Other
|
|
Otic Agents
|
|
Respiratory Tract/Pulmonary Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
USP Drug Classification